Factor VIII organisation on nanodiscs with different lipid composition

Thrombosis and Haemostasis

Volumn 113, Issue 4, 2015, Pages 741-749

  Grushin, Kirill ^a   Miller, Jaimy ^a   Dalm, Daniela ^a   Stoilova McPhie, Svetla ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Coagulation factors; Electron microscopy; Folding; Imaging; Phospholipids; Protein structure

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9A; BLOOD CLOTTING FACTOR8A; MEMBRANE SCAFFOLDING PROTEIN; NANODISC; PHOSPHATIDYLSERINE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; ARTIFICIAL MEMBRANE; MEMBRANE PROTEIN; NANOMATERIAL; PROTEIN BINDING; RECOMBINANT PROTEIN;

ANALYTICAL PARAMETERS; ARTICLE; BLOOD CLOTTING TIME; COMPLEX FORMATION; ELECTRON MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; LIGHT SCATTERING; LIPID COMPOSITION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PARTICLE DISTRIBUTION; PARTICLE SIZE; PIG; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; ALGORITHM; ANIMAL; ARTIFICIAL MEMBRANE; BINDING SITE; CHEMISTRY; IMAGE PROCESSING; METABOLISM; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING; TRANSMISSION ELECTRON MICROSCOPY;

ALGORITHMS; ANIMALS; BINDING SITES; FACTOR VIII; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MEMBRANE PROTEINS; MEMBRANES, ARTIFICIAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; PHOSPHATIDYLSERINES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SURFACE PROPERTIES; SWINE;

EID: 84931292069     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-09-0725     Document Type: Article

References (47)

1. Fay PJ. Activation of factor VIII and mechanisms of cofactor action. Blood Rev 2004; 18: 1-15.
2. Fay PJ. Factor VIII structure and function. Intern J Hematol 2006; 83: 103-108.
3. Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-haemophilic factor (factor VIII). Proc Natl Acad Sci USA 1988; 85: 2429-2433.
4. Fay PJ, Smudzin TM. Characterisation of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem 1992; 267: 13246-13250.
5. Wakabayashi H, Fay PJ. Identification of residues contributing to A2 domaindependent structural stability in factor VIII and factor VIIIa. J Biol Chem 2008; 283: 11645-11651.
6. Shen BW, Spiegel PC, Chang CH, et al. The tertiary structure and domain organisation of coagulation factor VIII. Blood 2008; 111: 1240-1247.
7. Derrick TS, Kashi RS, Durrani M, et al. Effect of metal cations on the conformation and inactivation of recombinant human factor VIII. J Pharm Sci 2004; 93: 2549-2557.
8. Lollar P, Parker CG. Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 1989; 28: 666-674.
9. Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962.
10. Duffy EJ, Parker ET, Mutucumarana VP, et al. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles. J Biol Chem 1992; 267: 17006-17011.
11. Pratt KP, Shen BW, Takeshima K, et al. Structure of the C2 domain of human factor VIII at 1. 5 A resolution. Nature 1999; 402: 439-442.
12. Lenting PJ, van Mourik JA, Mertens K. The life cycle of coagulation factor VIII in view of its structure and function. Blood 1998; 92: 3983-3996.
13. Hsu TC, Pratt KP, Thompson AR. The factor VIII C1 domain contributes to platelet binding. Blood 2008; 111: 200-208.
14. Ahmad SS, Walsh PN. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface. Biochemistry 2002; 41: 11269-11276.
15. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
16. Pipe SW. Haemophilia: new protein therapeutics. Hematology Am Soc Hematol Educ Program 2010; 2010: 203-209.
17. Shaw AW, Pureza VS, Sligar SG, et al. The local phospholipid environment modulates the activation of blood clotting. J Biol Chem 2007; 282: 6556-6563.
18. Ruprecht J, Nield J. Determining the structure of biological macromolecules by transmission electron microscopy, single particle analysis and 3D reconstruction. Progr Biophys Mol Biol 2001; 75: 121-164.
19. Grushin K, Miller J, Dalm D, et al. Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII. Haemophilia 2014; 20: 723-731.
20. Henderson R. The potential and limitations of neutrons, electrons and X-rays for atomic resolution microscopy of unstained biological molecules. Quart Rev Biophys 1995; 28: 171-193.
21. Frederik PM, Hubert DHW. Cryoelectron microscopy of liposomes. Methods Enzymol 2005; 391: 431-448.
22. Katayama H, Wang J, Tama F, et al. Three-dimensional structure of the anthrax toxin pore inserted into lipid nanodiscs and lipid vesicles. Proc Natl Acad Sci USA 2010; 107: 3453-3457.
23. Akkaladevi N, Hinton-Chollet L, Katayama H, et al. Assembly of anthrax toxin pore: lethal-factor complexes into lipid nanodiscs. Protein Sci 2013; 22: 492-501.
24. Gatti L, Mannucci PM. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb Haemost 1984; 51: 379-384.
25. Hay CR, Lozier JN, Lee CA, et al. Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haaemophilia-A and inhibitors: the results of an international survey. Thromb Haemost 1996; 75: 25-29.
26. Lollar P, Parker ET. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog. J Biol Chem 1991; 266: 12481-12486.
27. Lollar P, Parker ET, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 23652-23657.
28. Doering CB, Healey JF, Parker ET, et al. High level expression of recombinant porcine coagulation factor VIII. J Biol Chem 2002; 277: 38345-38349.
29. Miller J, Dalm D, Koyfman AY, et al. Helical organisation of blood coagulation factor VIII on lipid nanotubes. J Vis Exp 2014; Epub ahead of print.
30. Stoilova-McPhie S, Grushin K, Dalm D, et al. Lipid nanotechnologies for structural studies of membrane-associated proteins. Proteins 2014; 82: 2902-2909.
31. Ritchie TK, Grinkova YV, Bayburt TH, et al. Chapter 11-Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol 2009; 464: 211-231.
32. Pace CN, Vajdos F, Fee L, et al. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 1995; 4: 2411-2423.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
34. Tang G, Peng L, Baldwin PR, et al. EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 2007; 157: 38-46.
35. Parmenter CDJ, Stoilova-McPhie S. Binding of recombinant human coagulation factor VIII to lipid nanotubes. FEBS Lett 2008; 582: 1657-1660.
36. Blanchette CD, Law R, Benner WH, et al. Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations. J Lipid Res 2008; 49: 1420-1430.
37. Denisov IG, Grinkova YV, Lazaridesaa, et al. Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size. J Am Chem Soc 2004; 126: 3477-3487.
38. Stoilova-McPhie S, Lynch GC, Ludtke S, et al. Domain organisation of membrane-bound factor VIII. Biopolymers 2013; 99: 448-459.
39. Morrissey JH, Pureza V, Davis-Harrison RL, et al. Blood clotting reactions on nanoscale phospholipid bilayers. Thromb Res 2008; 122 (Suppl): S23-S26.
40. Grinkova YV, Denisov IG, Sligar SG. Engineering extended membrane scaffold proteins for self-assembly of soluble nanoscale lipid bilayers. Protein engineering design selection PEDS 2010; 23: 843-848.
41. Biró E, Akkerman JWN, Hoek FJ, et al. The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J Thromb Haemost 2005; 3: 2754-2763.
42. Demel Ra, Paltauf F, Hauser H. Monolayer characteristics and thermal behavior of natural and synthetic phosphatidylserines. Biochemistry 1987; 26: 8659-8665.
43. Smaby JM, Kulkarni VS, Momsen M, et al. The interfacial elastic packing interactions of galactosylceramides, sphingomyelins, and phosphatidylcholines. Biophys J 1996; 70: 868-877.
44. Stoylova SS, Lenting PJ, Kemball-Cook G, et al. Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers. J Biol Chem 1999; 274: 36573-36578.
45. Stoilova-McPhie S, Villoutreix BO, Mertens K, et al. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Blood 2002; 99: 1215-1223.
46. Stoylova S, Mann KG, Brisson A. Structure of membrane-bound human factor Va. FEBS Lett 1994; 351: 330-334.
47. Stoylova S, Gray E, Barrowcliffe TW, et al. Structural determination of lipidbound human blood coagulation factor IX. Biochim Biophys Acta 1998; 1383: 175-178.